LINC00520 has been widely reported in breast cancer, colorectal cancer, skin squamous cell carcinoma, melanoma, and other cancer cells, and shows increased expression in breast cancer tissue compared with normal breast tissue. Here, LINC00520 is linked to skin squamous cell carcinoma.